[go: up one dir, main page]

EE200000029A - 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid - Google Patents

5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid

Info

Publication number
EE200000029A
EE200000029A EEP200000029A EEP200000029A EE200000029A EE 200000029 A EE200000029 A EE 200000029A EE P200000029 A EEP200000029 A EE P200000029A EE P200000029 A EEP200000029 A EE P200000029A EE 200000029 A EE200000029 A EE 200000029A
Authority
EE
Estonia
Prior art keywords
naphthyridin
oxadiazolyl
derivatives
substituted
Prior art date
Application number
EEP200000029A
Other languages
English (en)
Inventor
Ohno Kazunori
Odai Osamu
Masumoto Kaoru
Furukawa Kiyoshi
Oka Makoto
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of EE200000029A publication Critical patent/EE200000029A/et
Publication of EE04372B1 publication Critical patent/EE04372B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200000029A 1997-07-15 1998-07-14 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid EE04372B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20717997 1997-07-15
PCT/JP1998/003134 WO1999003857A1 (en) 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Publications (2)

Publication Number Publication Date
EE200000029A true EE200000029A (et) 2000-10-16
EE04372B1 EE04372B1 (et) 2004-10-15

Family

ID=16535559

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000029A EE04372B1 (et) 1997-07-15 1998-07-14 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid

Country Status (28)

Country Link
US (2) US6172079B1 (et)
EP (1) EP1010699B1 (et)
JP (1) JP3390453B2 (et)
KR (1) KR100508392B1 (et)
CN (1) CN1134437C (et)
AR (1) AR013222A1 (et)
AT (1) ATE297923T1 (et)
AU (1) AU735960B2 (et)
BR (1) BR9811474B1 (et)
CA (1) CA2296427C (et)
DE (1) DE69830595T2 (et)
DK (1) DK1010699T3 (et)
EE (1) EE04372B1 (et)
ES (1) ES2244065T3 (et)
HU (1) HUP0004671A3 (et)
ID (1) ID24047A (et)
IL (2) IL133512A0 (et)
NO (1) NO314999B1 (et)
NZ (1) NZ501814A (et)
PL (1) PL191200B1 (et)
PT (1) PT1010699E (et)
RU (1) RU2188199C2 (et)
SI (1) SI1010699T1 (et)
SK (1) SK285913B6 (et)
TR (1) TR200000103T2 (et)
TW (1) TW486479B (et)
WO (1) WO1999003857A1 (et)
ZA (1) ZA985870B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298068B (en) * 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
KR20090081407A (ko) 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
AU2009217356B2 (en) * 2008-02-22 2012-05-03 Irm Llc Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
AU664912B2 (en) 1992-09-02 1995-12-07 Dainippon Pharmaceutical Co. Ltd. Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
JP2002241379A (ja) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd ３−オキサジアゾリルキノキサリン誘導体

Also Published As

Publication number Publication date
DE69830595T2 (de) 2006-05-11
HUP0004671A3 (en) 2001-12-28
CN1134437C (zh) 2004-01-14
DE69830595D1 (de) 2005-07-21
WO1999003857A1 (en) 1999-01-28
ZA985870B (en) 1999-01-27
KR20010021824A (ko) 2001-03-15
US6277993B1 (en) 2001-08-21
US6172079B1 (en) 2001-01-09
BR9811474B1 (pt) 2009-05-05
CA2296427A1 (en) 1999-01-28
PL338085A1 (en) 2000-09-25
ES2244065T3 (es) 2005-12-01
NO20000183L (no) 2000-03-07
NO20000183D0 (no) 2000-01-14
EP1010699A1 (en) 2000-06-21
ID24047A (id) 2000-07-06
CN1264380A (zh) 2000-08-23
EP1010699B1 (en) 2005-06-15
SI1010699T1 (en) 2005-10-31
HK1028895A1 (en) 2001-03-09
PT1010699E (pt) 2005-08-31
IL133512A (en) 2007-06-17
IL133512A0 (en) 2001-04-30
SK285913B6 (sk) 2007-11-02
AU735960B2 (en) 2001-07-19
NZ501814A (en) 2002-02-01
TW486479B (en) 2002-05-11
CA2296427C (en) 2006-11-14
PL191200B1 (pl) 2006-03-31
TR200000103T2 (tr) 2000-06-21
AU8129498A (en) 1999-02-10
HUP0004671A2 (hu) 2001-05-28
DK1010699T3 (da) 2005-10-10
NO314999B1 (no) 2003-06-23
KR100508392B1 (ko) 2005-08-17
EP1010699A4 (en) 2001-09-12
JP3390453B2 (ja) 2003-03-24
AR013222A1 (es) 2000-12-13
RU2188199C2 (ru) 2002-08-27
ATE297923T1 (de) 2005-07-15
SK532000A3 (en) 2000-09-12
BR9811474A (pt) 2000-08-15
EE04372B1 (et) 2004-10-15

Similar Documents

Publication Publication Date Title
IS5197A (is) Nikótínamíð afleiður
DE69804273D1 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
ATE393145T1 (de) Pyridinderivate
ATE284404T1 (de) Pyrazolo(4,3-d)pyrimidinderivate
ATE256123T1 (de) Pyrimidonderivate
PT1005446E (pt) Derivados de n-aroilfenilalanina
TR199800085A3 (tr) 8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri.
DK1218382T3 (da) Bicykliske imidazo-3-ylaminderivater
PT1104420E (pt) 1-aril-3-arilmetil-1,8-naftiridin-4(1h)-onas
PT915088E (pt) Derivados de d-prolina
DE50015443D1 (de) Bicyclische imidazo-5-yl-aminderivate
NO985684L (no) 1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
DE69900220D1 (de) Diaza-spiro[3,5]nonan-Derivate
ATE281436T1 (de) Chinolin-4-yl-derivate
NO20000183D0 (no) 5-substituerte-3-oksadiazolyl-1,6-naftyridin-2(1H)-on- derivater
NO20031412D0 (no) Substituerte 3,4-dihydro-pyrido[1,2-A]pyrimidiner
NO970366D0 (no) Imidazopyridinderivater
DK1326866T3 (da) Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090714